| Discovering multiple types of DNA methylation from bacteria and microbiome using nanopore sequencing A Tourancheau, EA Mead, XS Zhang, G Fang Nature Methods 18 (5), 491-498, 2021 | 107 | 2021 |
| Quantitative profiling of the UGT transcriptome in human drug-metabolizing tissues A Tourancheau, M Rouleau, S Guauque-Olarte, L Villeneuve, I Gilbert, ... The pharmacogenomics journal 18 (2), 251-261, 2018 | 49 | 2018 |
| Unravelling the transcriptomic landscape of the major phase II UDP-glucuronosyltransferase drug metabolizing pathway using targeted RNA sequencing A Tourancheau, G Margaillan, M Rouleau, I Gilbert, L Villeneuve, ... The pharmacogenomics journal 16 (1), 60-70, 2016 | 48 | 2016 |
| Divergent expression and metabolic functions of human glucuronosyltransferases through alternative splicing M Rouleau, A Tourancheau, C Girard-Bock, L Villeneuve, J Vaucher, ... Cell reports 17 (1), 114-124, 2016 | 34 | 2016 |
| A novel UGT1 marker associated with better tolerance against irinotecan-induced severe neutropenia in metastatic colorectal cancer patients S Chen, I Laverdiere, A Tourancheau, D Jonker, F Couture, E Cecchin, ... The pharmacogenomics journal 15 (6), 513-520, 2015 | 29 | 2015 |
| Cyclosporine and methotrexate-related pharmacogenomic predictors of acute graft-versus-host disease I Laverdière, C Guillemette, R Tamouza, P Loiseau, RP de Latour, ... haematologica 100 (2), 275, 2015 | 4 | 2015 |
| Discovering and exploiting multiple types of DNA methylation from individual bacteria and microbiome using nanopore sequencing A Tourancheau, EA Mead, XS Zhang, G Fang BioRxiv, 2020 | 3 | 2020 |
| Analyse bio-informatique de données de séquençage de nouvelle génération pour l'étude transcriptomique d'enzymes du métabolisme A Tourancheau | | 2016 |
